Evidence map›Paper›PMID 40949256›Full record

ArticleACS omega2025

Veronika Polakova, Jana Matulova, Jana Brtnikova, Zdenka Fohlerova, Kristyna Smerkova, Jozef Kaiser, Tomas Zikmund, Petra Prochazkova, Jan Zidek, Lucy Vojtova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Veronika PolakovaCentral European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic.ORCID https://orcid.org/0009-0001-0919-5313
Jana MatulovaCentral European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic.ORCID https://orcid.org/0000-0002-4072-8173
Jana BrtnikovaCentral European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic.ORCID https://orcid.org/0000-0002-5132-4094
Zdenka FohlerovaCentral European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic.ORCID https://orcid.org/0000-0002-1232-2301
Kristyna SmerkovaDepartment of Chemistry and Biochemistry, Faculty of AgriSciences, Mendel University in Brno, Zemedelska 1, 613 00 Brno, Czech Republic.ORCID https://orcid.org/0000-0002-1667-7660
Jozef KaiserCentral European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic.ORCID https://orcid.org/0000-0002-7397-125X
Tomas ZikmundCentral European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic.ORCID https://orcid.org/0000-0003-2948-5198
Petra ProchazkovaCentral European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic.ORCID https://orcid.org/0000-0001-9139-6175
Jan ZidekCentral European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic.ORCID https://orcid.org/0000-0001-9788-1403
Lucy VojtovaCentral European Institute of Technology, Brno University of Technology, Purkynova 123, 612 00 Brno, Czech Republic.ORCID https://orcid.org/0000-0001-5281-7045

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment of chronic wounds remains a major challenge in regenerative medicine due to prolonged healing times, susceptibility to infection, and underlying conditions like diabetes. Incorporating bioactive and antibacterial nanoparticles (NPs) into wound dressings can significantly enhance their mechanical properties, structural integrity, and functionality, improving stability, biocompatibility, and healing efficacy. However, conventional methods of loading NPs in polymer matrices often lead to uneven distribution and localized toxicity. To overcome these limitations, we employ a novel

Identifiers

PMID40949256
PMCPMC12423890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.